News
Threads
- MM-398 shows promise in phase 3 trial for pancreatic cancer (0 Replies)
- Vitamin E protective against cognitive impairment (1 Reply)
- Metreleptin wins FDA approval for lipodystrophy therapy (1 Reply)
- Genetic adaptation to high altitudes in Tibet (1 Reply)
- Tai Chi: can it slow down the aging process? (0 Replies)
- Genetic basis of schizophrenia involves multiple mutations (0 Replies)
- Calorie restriction and reduction of breast cancer metastasis (0 Replies)
- Rac1b: potential pancreatic cancer drug target (0 Replies)
- Future bright for faecal microbiota transplant therapy despite FDA regulation change (0 Replies)
- Triple-negative breast cancer: trial to develop personalised therapy (0 Replies)
- Sleeping sickness or not? Insight into differential trypanosome infectivity (0 Replies)
- Resveratrol in red wine insufficient to explain 'French Paradox' (0 Replies)
- Worldwide Protein Data Bank breaks 100,000 structures mark (0 Replies)
- Deadly pig virus causing international concern (0 Replies)
- Experimental antibody shows promise in Phase I trial for neuroblastoma (0 Replies)
- IPM-Janssen agreement: access to HIV Prevention Medicine in developing countries (0 Replies)
- Spider genome sequenced for first time: possible applications (0 Replies)
- Does breastfeeding promote healthy gut microbiota? (0 Replies)
- Hydrogel scaffold for new bone growth degrades when no longer needed (0 Replies)
- Concerns in UK over proposed AstraZeneca takeover by Pfizer (0 Replies)
- Possibilities for Amyotrophic Lateral Sclerosis therapy (0 Replies)
- Unpicking two locks to selectively deliver cancer therapy (0 Replies)
- AURORA: International molecular screening program for metastatic breast cancer (0 Replies)
- Hijack! Viruses plunder sulphur from deep-sea bacteria at hydrothermal vents (0 Replies)
- Look after your teeth! Dental pulp stem cells and potential stroke therapy (0 Replies)
- CANCP: new 50-Gene Cancer Panel Test launched by Mayo Clinic (0 Replies)
- Lab-on-a-chip with multiple applications (0 Replies)
- Skin grown in the lab can take place of animals to test drugs and cosmetics (0 Replies)
- Targeting the ‘supply chain’ of tumour cells with DNA vaccine (0 Replies)
- First targeted drug for stomach cancer approved by FDA (0 Replies)